View Older Stories View More Recent Stories

Nov 9, 2021 04:05PM Veracyte Announces Third Quarter 2021 Financial Results
Nov 5, 2021 08:15AM Veracyte (VCYT) Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-Asia
Nov 5, 2021 08:15AM Veracyte Announces Immunoscore Colon Cancer Test Included in ESMO Clinical Practice Guidelines Adapted for Pan-Asia
Nov 3, 2021 08:16AM Veracyte (VCYT) Announces New Publication Reinforcing Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis
Nov 3, 2021 08:15AM New Publication Reinforces Clinical Utility of Afirma Genomic Sequencing Classifier in Thyroid Cancer Diagnosis
Nov 2, 2021 08:15AM Veracyte Announces New Data To Be Presented at SITC 2021 Will Highlight Company’s Immuno-Oncology Capabilities
Oct 26, 2021 09:25AM New Data Demonstrate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier in Tailoring Treatment for Prostate Cancer Patients Experiencing Progression After Surgery
Oct 25, 2021 10:30AM Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate Cancer
Oct 14, 2021 08:38AM Veracyte (VCYT) Announces New Data Validating Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier
Oct 14, 2021 08:35AM New Data to be Presented at ASTRO 2021 Further Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier
Oct 13, 2021 08:55AM New Publication Demonstrates Ability of Veracyte’s Decipher Bladder Test to Identify Tumors Most Likely to Respond to Chemotherapy
Oct 12, 2021 04:05PM Veracyte to Release Third Quarter 2021 Financial Results on November 9, 2021
Oct 11, 2021 04:42PM Veracyte (VCYT) Announces New Clinical Utility Data Confirm its Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis
Oct 11, 2021 04:41PM New Clinical Utility Data Confirm Veracyte’s Envisia Genomic Classifier Increases Accuracy and Confidence in IPF Diagnosis
Oct 11, 2021 08:15AM Veracyte Announces New Expanded Data at CHEST Underscoring Percepta Nasal Swab Test’s Ability to Improve Early Lung Cancer Assessment
Oct 6, 2021 08:30AM New Data to be Presented at CHEST 2021 Showcase Clinical Performance of Veracyte’s Genomic Diagnostic Tests in Lung Cancer and Interstitial Lung Disease
Sep 14, 2021 04:05PM Veracyte Announces that New NCCN Guidelines Uniquely Recommend Use of Decipher Prostate Genomic Test Score to Guide Specific Treatment for Men Following Radical Prostatectomy
Sep 1, 2021 08:35AM Veracyte Further Strengthens Medical Team with Appointment of Joshua Klopper, M.D., as Medical Director of Endocrinology
Aug 31, 2021 08:15AM Veracyte to Participate in Morgan Stanley 19th Annual Global Healthcare Conference
Aug 23, 2021 10:33AM Veracyte Named a San Francisco Bay Area “Top Workplace” for Eighth Consecutive Year
Aug 3, 2021 08:00AM Veracyte Completes Acquisition of HalioDx
Jul 29, 2021 04:05PM Veracyte Announces Second Quarter 2021 Financial Results
Jul 27, 2021 04:05PM New Study Suggests Decipher Prostate Biopsy Test May Help Guide Use of Active Surveillance in Prostate Cancer
Jul 12, 2021 08:32AM Veracyte (VCYT) Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer
Jul 12, 2021 08:30AM Veracyte Appoints Rebecca Chambers as Executive Vice President and Chief Financial Officer, Further Positioning Company for Global Growth
Jul 8, 2021 04:05PM Veracyte to Release Second Quarter 2021 Financial Results on July 29, 2021
Jul 8, 2021 08:30AM Veracyte Announces Key Appointments to Executive Leadership Team, Supporting Global Expansion
Jul 1, 2021 08:45AM Veracyte Announces Two Pre-Eminent Physician Appointments, Further Strengthening Medical Team
Jun 14, 2021 08:45AM Veracyte (VCYT) Announces New Data Published in JAMA Oncology Demonstrate Prognostic Utility of its Decipher Prostate Genomic Classifier in Locally Advanced Prostate Cancer
Jun 14, 2021 08:45AM New Data Published in JAMA Oncology Demonstrate Prognostic Utility of Veracyte’s Decipher Prostate Genomic Classifier in Locally Advanced Prostate Cancer
Jun 4, 2021 09:24AM Veracyte (VCYT) Receives Final Medicare Coverage Policies for Decipher Bladder
Jun 4, 2021 09:24AM Veracyte Receives Final Medicare Coverage Policies for Decipher Bladder
Jun 2, 2021 03:00PM Veracyte to Present at Upcoming Investor Conferences
Jun 1, 2021 07:02AM Veracyte (VCYT) to Acquire HalioDx
Jun 1, 2021 07:00AM Veracyte to Acquire HalioDx, Positioning for Global Cancer Diagnostics Growth
May 26, 2021 03:00PM Veracyte to Present at Upcoming Investor Conferences
May 26, 2021 09:05AM Veracyte (VCYT) Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA Samples
May 26, 2021 09:05AM Veracyte Announces New Data Demonstrating Afirma Xpression Atlas Identifies Clinically Relevant Gene Fusions in Thyroid Cancer FNA Samples
May 25, 2021 09:00AM Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic Classifier
May 19, 2021 05:03PM Veracyte (VCYT) Announces New Pivotal Clinical Validation Data at ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection
May 19, 2021 05:00PM Veracyte Announces New Pivotal Clinical Validation Data at ASCO Showing Noninvasive Nasal Swab Test Can Significantly Improve Early Lung Cancer Detection
May 18, 2021 05:15PM Veracyte to Present at Upcoming Investor Conferences
May 14, 2021 04:35PM Veracyte Announces Data Reinforcing the Diagnostic Performance and Utility of the Envisia Genomic Classifier in ILD Diagnosis
May 14, 2021 12:45PM Veracyte (VCYT) Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy
May 14, 2021 12:45PM Veracyte Announces Data Showing Percepta Genomic Atlas Detects Gene Alterations Targeted in Lung Cancer Treatment, Using Diagnostic Biopsy
May 10, 2021 04:10PM Veracyte, Inc. Announces CEO Succession Plan
May 10, 2021 04:05PM Veracyte Announces First Quarter 2021 Financial Results
May 4, 2021 04:45PM Veracyte Announces New Data Relating to Prosigna Breast Cancer Test to Be Presented at ESMO Breast Cancer Virtual Congress
Apr 29, 2021 08:30AM Veracyte to Unveil Practice-Changing Genomic Diagnostics Data Across Multiple Oncology Indications at 2021 ASCO
Apr 27, 2021 04:48PM Veracyte (VCYT) Announces Publication of Study Showing Robust Performance of Percepta GSC in Improving Lung Cancer Diagnosis
View More Recent Stories View Older Stories